ストックスクリーナーアプリを入手
74.26
1.56%
1.14
前日終値:
$73.12
開ける：
$73
24時間の取引高:
1.14M
Relative Volume:
0.92
時価総額：
$12.85B
収益：
$8.31B
当期純損益:
$379.00M
株価収益率:
34.38
EPS:
2.16
ネットキャッシュフロー:
$385.00M
1週間 パフォーマンス:
+2.39%
1か月 パフォーマンス:
+9.82%
6か月 パフォーマンス:
+4.93%
1年 パフォーマンス:
+30.17%
1日の値動き範囲:
$72.41
$74.51
1週間の範囲:
$71.34
$74.51
52週間の値動き範囲:
$47.16
$85.92
Solventum Corp Stock (SOLV) Company Profile
SOLV を他の銘柄と比較する
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
SOLV
Solventum Corp
|
74.26 | 12.55B | 8.31B | 379.00M | 385.00M | 2.16 |
|
ISRG
Intuitive Surgical Inc
|
551.85 | 197.20B | 8.71B | 2.48B | 1.75B | 6.82 |
|
BDX
Becton Dickinson Co
|
170.66 | 50.02B | 20.87B | 1.50B | 2.59B | 5.24 |
|
ALC
Alcon Inc
|
85.43 | 42.88B | 9.93B | 1.12B | 1.58B | 2.25 |
|
RMD
Resmed Inc
|
247.05 | 36.10B | 5.02B | 1.31B | 1.56B | 8.91 |
|
BAX
Baxter International Inc
|
30.09 | 15.84B | 11.89B | -560.00M | 191.00M | -1.10 |
Solventum Corp Stock (SOLV) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2025-05-19 | アップグレード | Piper Sandler | Neutral → Overweight |
| 2024-12-04 | 開始されました | Mizuho | Neutral |
| 2024-10-08 | 開始されました | Stifel | Buy |
| 2024-10-07 | 開始されました | Piper Sandler | Neutral |
| 2024-09-26 | 開始されました | Wolfe Research | Peer Perform |
| 2024-09-05 | 開始されました | BTIG Research | Neutral |
| 2024-06-24 | 開始されました | Argus | Hold |
| 2024-05-30 | 開始されました | Goldman | Sell |
| 2024-05-10 | 開始されました | BofA Securities | Neutral |
| 2024-04-10 | 開始されました | Morgan Stanley | Equal-Weight |
| 2024-04-08 | 開始されました | Wells Fargo | Equal Weight |
| 2024-04-02 | 開始されました | Edward Jones | Hold |
すべてを表示
Solventum Corp (SOLV) 最新ニュース
Solventum to Participate in the 2025 Goldman Sachs Health Care Conference - marketscreener.com
Solventum Leadership to Share Strategic Insights at Goldman Sachs Healthcare Conference - Stock Titan
SOLV's Strong Q1 Signals Turnaround: Is the Stock Worth Betting Now? - TradingView
Ensemble and Solventum to launch autonomous coding solution for hospitals - MSN
Solventum Stock Outlook: Is Wall Street Bullish or Bearish? - MSN
Ameriprise Financial Inc. Boosts Stake in Solventum Co. (NYSE:SOLV) - Defense World
Piper Sandler Upgrades Solventum (BIT:1SOLV) - Nasdaq
Piper Sandler Upgrades Solventum (LSE:0AD1) - Nasdaq
Ensemble and Solventum Partner to Advance Autonomous Inpatient Coding with AI - The Manila Times
Piper Sandler Upgrades Solventum (BMV:SOLV) - Nasdaq
Piper Sandler Upgrades Solventum (SOLV) - Nasdaq
Assessing Solventum: Insights From 9 Financial Analysts - Benzinga
Piper Sandler raises Solventum stock to Overweight, target to $87 By Investing.com - Investing.com Nigeria
Piper Sandler raises Solventum stock to Overweight, target to $87 - Investing.com
Piper Sandler Upgrades Solventum to Overweight From Neutral, Adjusts Price Target to $87 From $78 - marketscreener.com
Solventum upgraded to Overweight from Neutral at Piper Sandler - TipRanks
Promising Growth and Strategic Flexibility: A Buy Recommendation for Solventum Corporation - TipRanks
After spinoff, 3M is no longer one of Minnesota’s five largest public companies - MSN
Solventum's (NYSE:SOLV) Shareholders Have More To Worry About Than Only Soft Earnings - simplywall.st
Solventum's (NYSE:SOLV) Problems Go Beyond Weak Profit - Yahoo Finance
Solventum Stock Outlook: Is Wall Street Bullish Or Bearish? - Barchart.com
Solventum Meets 80-Plus Relative Strength Rating Benchmark - Investor's Business Daily
People moves: Linda Pazin joins Solventum and Mitch Haws moves to Semtech - IR Impact
Solventum To Present At BofA Securities Health Care Conference; Webcast At 5:20 PM ET - Nasdaq
Solventum sells purification business for $4.1B to pay down debt - MSN
Solventum Corp. stock rises Monday, outperforms market - MarketWatch
Solventum, Envista, ICU Medical, Globus Medical, and Enovis Stocks Trade Up, What You Need To Know - MSN
Solventum’s projected $100M tariff hit prevents earnings increase - MedTech Dive
Solventum (SOLV) Just Overtook the 200-Day Moving Average - Nasdaq
Solventum Stock Gains on Q1 Earnings & Revenue Beat, Margins Decline - MSN
Solventum, facing tariffs of up to $100 million, raises sales guidance - MSN
Solventum Corporation Beat Analyst Estimates: See What The Consensus Is Forecasting For This Year - simplywall.st
Decoding Solventum Corp (SOLV): A Strategic SWOT Insight - GuruFocus
Solventum beats first-quarter profit estimates on strong surgical product sales - MSN
Solventum (SOLV) Q1 Earnings: How Key Metrics Compare to Wall Street Estimates - MSN
Solventum beats The Street in Q1 and ups revenue guidance - MassDevice
Solventum Corp. stock rises Friday, outperforms market - MarketWatch
Solventum Corporation: Cheap, With Caveats (NYSE:SOLV) - Seeking Alpha
Health care manufacturer Solventum faces $100 million tariff hit despite strong Q1 - The Business Journals
Solventum price target lowered to $78 from $80 at Piper Sandler - TipRanks
Solventum Q1 FY25 presentation: raises organic sales outlook despite tariff headwinds - Investing.com
Solventum: Q1 Earnings Snapshot - New Haven Register
Solventum Corp (SOLV) Q1 2025 Earnings Call Highlights: Strong Organic Growth Amid Tariff Challenges - Investing.com Canada
Solventum sees FY25 adjusted EPS $5.45-$5.65, consensus $5.54 - TipRanks
Earnings call transcript: Solventum’s Q1 2025 results show mixed performance - Investing.com
Solventum reports Q1 adjusted EPS $1.34, consensus $1.22 - TipRanks
Solventum Corp (SOLV) 財務データ
収益
当期純利益
現金流量
EPS
0.36%
0.13%
大文字化:
|
ボリューム (24 時間):